These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9692346)

  • 21. Enhanced generation of leukotriene B4 by neutrophils stimulated by unopsonized zymosan and by calcium ionophore after exercise-induced asthma.
    Arm JP; Horton CE; House F; Clark TJ; Spur BW; Lee TH
    Am Rev Respir Dis; 1988 Jul; 138(1):47-53. PubMed ID: 2849339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of two novel inhibitors of 5-lipoxygenase, L-651,392 and L-651,896, in a guinea-pig model of epidermal hyperproliferation.
    Chan CC; Dubois L; Young V
    Eur J Pharmacol; 1987 Jul; 139(1):11-8. PubMed ID: 2820754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-inflammatory effect of YPE-01, a novel diarylheptanoid derivative, on dermal inflammation in mice.
    Yamazaki R; Aiyama R; Matsuzaki T; Hashimoto S; Yokokura T
    Inflamm Res; 1998 Apr; 47(4):182-6. PubMed ID: 9628261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-Lipoxygenase inhibitors: synthesis and structure-activity relationships of a series of 1-aryl-2H,4H-tetrahydro-1,2,4-triazin-3-ones.
    Bhatia PA; Brooks CD; Basha A; Ratajczyk JD; Gunn BP; Bouska JB; Lanni C; Young PR; Bell RL; Carter GW
    J Med Chem; 1996 Sep; 39(20):3938-50. PubMed ID: 8831760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lung cancer cell lines inhibit leukotriene B4 production by human polymorphonuclear leukocytes at the level of phospholipase A2.
    Abe M; Matsuki H; Domae M; Kuwata H; Kudo I; Nakanishi Y; Hara N; Mitsuyama T; Furukawa T
    Am J Respir Cell Mol Biol; 1996 Nov; 15(5):565-73. PubMed ID: 8918363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of 1,5-diarylpyrazol-3-propanoic acids towards inhibition of cyclooxygenase-1/2 activity and 5-lipoxygenase-mediated LTB4 formation.
    Ergün BC; Nuñez MT; Labeaga L; Ledo F; Darlington J; Bain G; Cakir B; Banoglu E
    Arzneimittelforschung; 2010; 60(8):497-505. PubMed ID: 20863006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RANTES (CCL5) potentiates calcium ionophore in the production of LTB4 in rat adherent macrophages from granuloma induced by KMnO4: inhibiton by NDGA.
    Anogianaki A; Castellani ML; Madhappan B; Salini V; Vecchiet J; Tetè S; Frydas S; Perrella A; De Lutiis MA; Neri G; Cerulli G; Caraffa A; Conti P
    Pharmacol Res; 2008 Jan; 57(1):49-55. PubMed ID: 18083043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipoxygenase inhibitory activity of U-66,858 and its deacetylated metabolite U-68,244 in human whole blood.
    Summers JA; Bye A; Robinson C
    Agents Actions; 1994 Mar; 41(1-2):32-6. PubMed ID: 8079818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proliferative responses of normal human mammary and MCF-7 breast cancer cells to linoleic acid, conjugated linoleic acid and eicosanoid synthesis inhibitors in culture.
    Cunningham DC; Harrison LY; Shultz TD
    Anticancer Res; 1997; 17(1A):197-203. PubMed ID: 9066651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of apoptosis in eicosapentaenoic acid-treated HL-60 cells.
    Gillis RC; Daley BJ; Enderson BL; Kestler DP; Karlstad MD
    J Surg Res; 2007 Jan; 137(1):141-50. PubMed ID: 17084410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formation and effects of leukotriene B4 in human lymphocytes.
    Odlander B; Jakobsson PJ; Medina JF; Rådmark O; Yamaoka KA; Rosén A; Claesson HE
    Int J Tissue React; 1989; 11(6):277-89. PubMed ID: 2561484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-lipoxygenase regulates malignant mesothelial cell survival: involvement of vascular endothelial growth factor.
    Romano M; Catalano A; Nutini M; D'Urbano E; Crescenzi C; Claria J; Libner R; Davi G; Procopio A
    FASEB J; 2001 Nov; 15(13):2326-36. PubMed ID: 11689458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of human cancer cell proliferation by lipoxygenase inhibitors and gamma-radiation in vitro.
    Hofmanová J; Musilová E; Kozubík A
    Gen Physiol Biophys; 1996 Aug; 15(4):317-31. PubMed ID: 9088929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphorylation- and stimulus-dependent inhibition of cellular 5-lipoxygenase activity by nonredox-type inhibitors.
    Fischer L; Szellas D; Rådmark O; Steinhilber D; Werz O
    FASEB J; 2003 May; 17(8):949-51. PubMed ID: 12670876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils.
    Lee TH; Mencia-Huerta JM; Shih C; Corey EJ; Lewis RA; Austen KF
    J Clin Invest; 1984 Dec; 74(6):1922-33. PubMed ID: 6096400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Murine glomerular leukotriene B4 synthesis. Manipulation by (n-6) fatty acid deprivation and cellular origin.
    Lefkowith JB; Morrison AR; Schreiner GF
    J Clin Invest; 1988 Nov; 82(5):1655-60. PubMed ID: 2846657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BIRM 270: a novel inhibitor of arachidonate release that blocks leukotriene B4 and platelet-activating factor biosynthesis in human neutrophils.
    Farina PR; Graham AG; Hoffman AF; Watrous JM; Borgeat P; Nadeau M; Hansen G; Dinallo RM; Adams J; Miao CK
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1418-26. PubMed ID: 7996454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of leukotriene formation in human leukocytes by halothane.
    Yamaoka A; Sumimoto H; Takeshige K; Itoh T; Isobe R; Yoshitake J; Minakami S
    Biochim Biophys Acta; 1987 Apr; 918(3):284-92. PubMed ID: 3032266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of lipoxygenase in human bladder carcinoma and growth inhibition by its inhibitors.
    Yoshimura R; Matsuyama M; Tsuchida K; Kawahito Y; Sano H; Nakatani T
    J Urol; 2003 Nov; 170(5):1994-9. PubMed ID: 14532840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions.
    Avis I; Hong SH; Martinez A; Moody T; Choi YH; Trepel J; Das R; Jett M; Mulshine JL
    FASEB J; 2001 Sep; 15(11):2007-9. PubMed ID: 11511519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.